-
公开(公告)号：US20240277231A1
公开(公告)日：2024-08-22
申请号：US18643098
申请日：2024-04-23
申请人： AILLIS INC.
IPC分类号： A61B5/00 , A61B5/0205 , G16H10/20 , G16H30/40 , G16H50/20
CPC分类号： A61B5/0088 , A61B5/0077 , A61B5/02055 , G16H10/20 , G16H30/40 , G16H50/20
摘要： A processing device is provided, comprising: at least one processor configured to execute a computer readable instructions so as to: acquire one or a plurality of determination images of a subject imaged by a camera from the imaging device including the camera for imaging an image of the subject including at least a part of an oral cavity of a user, acquire biometric detection information of the subject different from the one or the plurality of determination images from the imaging device, determine a possibility of morbidity for a predetermined disease on the basis of a learned determination model stored in a memory for determining the possibility of morbidity for the predetermined disease, the one or the plurality of acquired determination images, and the biometric detection information, and output information indicating the determined possibility of morbidity.
-
22.发明公开公开(公告)号：US20240274267A1
公开(公告)日：2024-08-15
申请号：US18166759
申请日：2023-02-09
申请人： InnateVR, LLC
发明人： Jacob Ziemba , Paul Ziemba
CPC分类号： G16H20/70 , G02B27/017 , G06T19/006 , G16H10/20 , G16H40/67 , G16H50/20
摘要： A virtual reality substance abuse treatment simulation is generated using input specific to a patient. The input indicates a type of substance used by the patient and one or more triggers for inducing substance use of that type of substance by the patient. At a computing device with which a virtual reality headset worn by the patient is in communication, instructions for running the virtual reality substance abuse treatment simulation are executed. Stimuli content associated with the type of substance and the one or more triggers are rendered as output for display at the virtual reality headset. Data indicative of exposures of the patient to ones of the stimuli content during the virtual reality substance abuse treatment simulation are transmitted to a remote device. Accordingly, a patient using the virtual reality substance abuse treatment simulation may experience a customized simulation tailored to their needs.
-
公开(公告)号：US20240274030A1
公开(公告)日：2024-08-15
申请号：US18166683
申请日：2023-02-09
申请人： Christina Toliver
发明人： Christina Toliver
摘要： Smash Therapy is a Method of Mental Health Therapy that combines smashing and psychotherapy delivered via traditional smashing as offered by rage rooms and includes the guided assistance of a psychotherapist to assist in the release of pent up frustration. The second method of delivery of Smash Therapy is through a virtual reality Smash Therapy metaverse that is being developed based on ongoing research and development and includes the Smash Therapy methodology accessible via any Virtual Reality mechanism, and the third method of delivery is through our Mobile Smash Clinics, which delivers Smash Therapy directly to the client location. Smash Therapy includes frequency, duration, and stimulation guidelines that formulate effective delivery of this method of mental health therapy collected through surveys conducted with previous clients incorporated into the design and testing is ongoing.
-
24.发明公开公开(公告)号：US20240266016A1
公开(公告)日：2024-08-08
申请号：US18411112
申请日：2024-01-12
摘要： A system automating extraction and unification of health data resources. Health data received from various sources is in the form of structured or unstructured health information. The system extracts health entities from unstructured data. Converts health resources in the various formats including FHIR-DSTU2, FHIR-STU3, Fhir-R4, C-CDA and Dicom image metadata to a common target format of FHIR R4. Highlight feature ‘Resource linking’ implements business intelligence through which it establishes connections amongst related health resources and generates unified health records. Allows integration and visualization of high quality Dicom images along with rest of the health data in one single platform. Supports global content search which allows user to enter any key word(s) and fetch all relevant health records spanning across various health data resources. The system also aims at maximum positive user experience through easy to use, intuitive, efficient and user centric User Interface design.
-
公开(公告)号：US20240266008A1
公开(公告)日：2024-08-08
申请号：US18163157
申请日：2023-02-01
申请人： Unlearn.AI, Inc.
CPC分类号： G16H10/20 , A61B5/4848 , G16H50/70
摘要： Systems and methods for designing random control trials in accordance with embodiments of the invention are illustrated. One embodiment includes a method for designing a target random control trial. The method includes steps for generating a set of prognostic scores for a set of samples. The set of prognostic scores includes prognostic scores at each of several points in time for each sample. The method includes assessing discrimination and bias metrics for the set of generative models based on a set of outcomes for the set of samples that includes outcomes at each of several points in time for each sample. The method includes determining a set of target trial parameters for a randomized control trial (RCT) based on the assessed discrimination and bias metrics, generating result data using the set of generative models, and determining treatment effects for the RCT using the generated result data.
-
公开(公告)号：US20240256427A1
公开(公告)日：2024-08-01
申请号：US18630687
申请日：2024-04-09
发明人： Jason Trees , Titiimaea Alailima
CPC分类号： G06F11/3616 , G06F11/3466 , G06F11/3612 , G06F17/18 , G16H10/20
摘要： Systems and methods for distributed scientific evaluation of software product comprising a digital health intervention or software as a medical device product. In certain embodiments, a scientific evaluation system is operably configured to analyze one or more safety, efficacy, performance, and/or quality assurance aspects for program code outputs of the software product. In further embodiments, a scientific evaluation system is operably configured to configure and administer a distributed scientific evaluation, research study and/or clinical trial for the software product. In certain embodiments, a scientific evaluation system is configured to enable scientific evaluation of one or more program code outputs of a software product for one or more indication or intended use.
-
公开(公告)号：US20240252067A1
公开(公告)日：2024-08-01
申请号：US18406847
申请日：2024-01-08
CPC分类号： A61B5/14532 , A61B5/0004 , A61B5/7435 , A61B5/7475 , G16H10/20
摘要： Systems and methods for displaying metrics related to a user are described. Data indicative of glucose levels of the user is received. A first alert point for a potential glucose episode in a data set of time correlated glucose data, e.g., a glucose vs. time curve, is identified if the last received glucose data point satisfies at least one alert condition. A first potential local minimum in a first time period is identified. The first potential local minimum is confirmed as a first start point of a first glucose episode if the first potential local minimum satisfies at least one local minimum condition. An integrated area under the curve over time of a first portion of the graph beginning at the first start point of the first glucose episode to the first alert point is calculated. A first count value is assigned to the first portion.
-
公开(公告)号：US12042266B2
公开(公告)日：2024-07-23
申请号：US16981609
申请日：2019-03-14
IPC分类号： A61B5/107 , A61B5/00 , A61B5/055 , A61B6/03 , G06T7/62 , G16H10/20 , G16H10/40 , G16H30/20 , G16H30/40 , G16H40/20 , G16H40/67 , G16H50/20 , G16H50/30 , G16H50/50
CPC分类号： A61B5/1073 , A61B5/055 , A61B5/1075 , A61B5/4842 , A61B5/7475 , A61B6/032 , G06T7/62 , G16H10/20 , G16H10/40 , G16H30/20 , G16H30/40 , G16H40/20 , G16H40/67 , G16H50/20 , G16H50/30 , G16H50/50 , G06T2207/10081 , G06T2207/10088 , G06T2207/30084
摘要： An apparatus and computerized method of classifying a patient that has been previously diagnosed to have autosomal dominant polycystic kidney disease (ADPKD) includes providing a computing device having an input/output interface, one or more processors and a memory; receiving a total kidney volume (TKV), a patient height, and a patient age for the patient via the input/output interface; determining a height adjusted TKV (HtTKV) based on the total kidney volume and the patient height using the one or more processors; determining an ADPKD classification for the patient based on the height adjusted TKV and the patient age using the one or more processors; and providing the ADPKD classification for the patient via the input/output interface.
-
公开(公告)号：US20240242815A1
公开(公告)日：2024-07-18
申请号：US18572902
申请日：2022-06-24
发明人： Andrew BLACKWELL , Danah Barbara TANGEN , Michael EWBANK , Thomas Fabian James CLELFORD , Mihai Valentin TABLAN , Jennifer GENTILE , Sabine Nicole BUCHHOLZ , Stephen FREER , Ana Maria Ferreira Paradela Catarino WINGFIELD , Ronan Patrick CUMMINS , Shaun MEHEW , Emily MARSHALL
摘要： A conversational agent is provided for maintaining or improving the wellbeing of a user presenting with diabetes and mental health needs by the delivery of a care protocol. The conversational agent comprises: a plurality of sub-dialogue units, each configured to deliver an element of the care protocol, and an orchestrator configured to present the sub-dialogue units to the user, sequentially, wherein each sub-dialogue unit and the orchestrator comprises: a natural language understanding module configured to receive an input and/or reply and determine at least one intent and, where present, at least one slot within the input and/or reply: a dialogue planning module configured to determine an output based, at least in part, on the at least one intent and/or slot associated within the input and/or reply, and a natural language generation module configured to provide the output to the user.
-
公开(公告)号：US20240242790A1
公开(公告)日：2024-07-18
申请号：US18559390
申请日：2022-04-26
CPC分类号： G16H10/20 , A61B5/6893 , A61B5/7221 , A61B5/7275 , A61B5/742
摘要： The present invention relates to a system (1) for assisting with provision of diagnostic information, especially with a view to detecting a disease in a person, especially a contagious disease such as COVID-19, this detecting system comprising: —a device (7) for acquiring examination data on the person, this acquiring device especially comprising, to acquire these examination data, at least a sensor, such as a radar, for measuring physiology and a thermal camera, this acquiring device comprising a plurality of sensors arranged to operate without contact with the person, at least one of the contactless sensors being arranged to acquire a response datum provided by the person.
-
-
-
-
-
-
-
-
-
搜索结果
2766 条记录 (耗时 0.044 秒)
